K. Martin

发表

Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis

A. Benson, J. Linder, S. Khan, 2020, Research and practice in thrombosis and haemostasis.

Efficacy and Safety of Direct Oral Anticoagulants for Atrial Fibrillation Across Body Mass Index Categories

R. Passman, L. Rasmussen-Torvik, S. Vupputuri, 2020, Journal of the American Heart Association.

Long-term antithrombotic therapy after venous stent placement

K. Desai, B. Stein, K. Martin, 2019, Phlebology.

Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN‐associated portal hypertension

J. Mondschein, M. Streiff, J. Spivak, 2017, American journal of hematology.

Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018

S. Khan, M. Cuttica, K. Desai, 2020, Journal of the American Heart Association.

Physician perceptions and use of reduced‐dose direct oral anticoagulants for extended phase venous thromboembolism treatment

M. Eyster, M. Gaddh, R. Rosovsky, 2022, Research and practice in thrombosis and haemostasis.

Heparin-induced thrombocytopenia testing is over-utilized in cirrhosis & correlates with poor clinical outcomes.

L. Kulik, N. Parikh, B. McMahon, 2014, Annals of hepatology.

Direct oral anticoagulants in extremely obese patients: OK to use?

D. Crona, S. Moll, K. Martin, 2018, Research and practice in thrombosis and haemostasis.

Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis

K. Martin, 2017, Current Hematologic Malignancy Reports.

Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

P. Sandset, M. Huisman, B. Davidson, 2016, Journal of thrombosis and haemostasis : JTH.

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.

B. Stein, K. Martin, 2019, Hematology. American Society of Hematology. Education Program.

From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms.

B. Stein, K. Martin, Karlyn Martin, 2019, Blood.

Long-term antithrombotic therapy after venous stent placement

K. Desai, B. Stein, K. Martin, 2018, Phlebology.

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

P. Sandset, M. Huisman, B. Davidson, 2021, Journal of thrombosis and haemostasis : JTH.

Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond.

M. Cuttica, K. Martin, 2021, Hematology. American Society of Hematology. Education Program.

Direct oral anticoagulant drug level testing in clinical practice: A single institution experience.

S. Moll, K. Martin, 2016, Thrombosis research.

Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.

Craig R. Lee, T. Farrell, S. Moll, 2017, The American journal of medicine.

Racial Disparities Exist Across Age Groups in Illinois for Pulmonary Embolism Hospitalizations

J. Feinglass, S. Khan, K. Martin, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Risk, Racial Disparity, and Outcomes Among Patients With Cancer and COVID-19 Infection.

Vaibhav Kumar, K. Martin, M. Grant, 2021, JAMA oncology.

Lower doses of recombinant porcine factor VIII maintain excellent haemostatic efficacy

N. Key, R. Kasthuri, K. Martin, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

How I treat patients with inherited bleeding disorders who need anticoagulant therapy.

N. Key, K. Martin, 2016, Blood.

Molecular basis of hemostatic and thrombotic diseases

N. Key, A. Ma, K. Martin, 2020, Essential Concepts in Molecular Pathology.

Dual Antithrombotic Therapy Targeting Residual Risk for Atherosclerotic Cardiovascular Disease: Does Body Mass Index Matter?

S. Khan, K. Martin, 2021, Journal of the American College of Cardiology.

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

D. Sudheendra, S. Goldhaber, T. Ortel, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Inferior Vena Cava Thrombosis Risk in 1582 Patients with Inferior Vena Cava Filters.

M. Cuttica, K. Desai, D. Schimmel, 2022, Radiology.

Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience

I. Goldberg, M. Cuttica, F. Rahaghi, 2023, Journal of Thrombosis and Thrombolysis.

Chronic throm bo em bolic pul mo nary hyper ten sion: anticoagulation and beyond

M. Cuttica, K. Martin, 2021 .

Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial.

C. Torrice, N. Key, R. Grant, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pulmonary embolism–related mortality during the COVID‐19 pandemic: Data from the United States

S. Khan, K. Martin, Katharine Harrington, 2022, Research and Practice in Thrombosis and Haemostasis.

Anticoagulation practice patterns in COVID‐19: A global survey

S. Kahn, M. Huisman, B. Kevane, 2020, Research and Practice in Thrombosis and Haemostasis.

Barriers and facilitators to preventing venous thromboembolism in oncology practice.

K. Cameron, K. Martin, Madison J. Lyleroehr, 2022, Thrombosis Research.

DOAC compared with warfarin for VTE in low weight patients: A retrospective cohort study conducted through the VENUS network.

M. Eyster, R. Rosovsky, S. Woller, 2023, Thrombosis research.

DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network

M. Eyster, R. Rosovsky, S. Woller, 2023, Journal of Thrombosis and Thrombolysis.